Explained herein are pharmaceutical packaging devices which stop oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive medication, such units which include a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with